Due to the numerous etiologies of CKD and the complex interactions of the multiple pathophysiological processes involved, a panel of biomarkers (and not just a single one) including ILK measurement could be necessary to improve this predictive ability. The gene discussed is ILK; the disease is chronic kidney disease.